This announcement is a separate document:
JMS：帝人ファーマとジェイ・エム・エス 腹膜透析を主とする合弁会社設立の契約を締結
JMS: Teijin Pharma and JMS signed an agreement to establish a joint venture focusing on peritoneal dialysis
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.